During a 2-year prospective cohort study in Mumbai, 10,000 initially disease-free adults aged 40–50 years were followed to assess the incidence of hypertension. At baseline (Year 0), none had hypertension. At the end of Year 1, 200 new cases of hypertension were identified. At the end of Year 2, an additional 150 new cases were identified (total 350 cases). The investigators want to calculate the cumulative incidence of hypertension over the 2-year period. What is the cumulative incidence, and what does this measure represent?

Explanation

## Cumulative Incidence Calculation **Cumulative Incidence (Risk)** is calculated as: $$\text{Cumulative Incidence} = \frac{\text{Number of new cases during follow-up period}}{\text{Number of disease-free individuals at start}} \times 100$$ In this scenario: - Number of new cases over 2 years = 350 - Number of disease-free individuals at baseline = 10,000 - Cumulative Incidence = (350 / 10,000) × 100 = **3.5%** ## Cumulative Incidence vs. Incidence Rate | Measure | Formula | Interpretation | Time Dimension | |---------|---------|-----------------|----------------| | **Cumulative Incidence (Risk)** | New cases / At-risk population | Proportion developing disease over a defined period | Fixed period (e.g., 2 years) | | **Incidence Rate** | New cases / Person-time at risk | Instantaneous rate of disease occurrence | Per unit time (e.g., per 1,000 per year) | **Key Point:** Cumulative incidence is a *proportion* (dimensionless, ranges 0–1 or 0–100%); it answers "What is the probability that a disease-free person will develop the disease over a specified period?" This is also called **risk**. ## Person-Time Calculation (for reference) If we assume all 10,000 individuals were followed for the full 2 years: - Total person-years = 10,000 × 2 = 20,000 person-years - Incidence rate = 350 / 20,000 = 0.0175 per person-year = 17.5 per 1,000 per year **High-Yield:** Cumulative incidence is preferred when: - Follow-up time is fixed and uniform across participants - You want to communicate disease risk to patients ("Your 2-year risk is 3.5%") - Loss to follow-up is minimal Incidence rate is preferred when: - Follow-up times vary among participants - Participants enter and exit the cohort at different times - You need to account for varying exposure duration **Clinical Pearl:** In clinical practice, cumulative incidence is often used to communicate risk. For example, "The 5-year risk of myocardial infarction in men with this risk profile is 8%." This is cumulative incidence, not incidence rate. **Mnemonic:** **C**umulative **I**ncidence = **C**losed cohort, **I**dentical follow-up time (simplified); **I**ncidence **R**ate = **I**ndividual variation in **R**isk time.